IRadimed Corporation

NASDAQ:IRMD

Medical - Devices

Healthcare
$82.31 +0.73%

+$0.67 today

Market cap
$1.05B
Beta
0.92
P/E (TTM)
49.7
EPS (TTM)
$1.85
Dividend yield
1.35%
52W Low $55.11High $107.90

Volume 0.08M

Average 0.12M

IRMD Total Liabilities

Everything the company owes to creditors and other parties.

IRadimed CorporationNASDAQ: IRMD

Total Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total liabilities rises 36.0% from a year ago

Total liabilities stood at $15.88M at the end of Q1 FY2026, up 36.0% from a year earlier and up 12.1% from the prior quarter. Over 3 fiscal years it compounded at +6.1% a year.

Context

  • Total liabilities amounted to 13.9% of total assets at the end of Q1 FY2026, up 2.4 pp from a year earlier.
  • Total liabilities increased in 2 of the last 3 fiscal years.

What to watch

Whether total liabilities keeps rising in the next quarterly balance sheet after a +36.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$15.88M+12.1% QoQ
Last fiscal yearDec 2025
$14.16M+23.0% YoY
Year agoMar 2025
$11.68M+36.0% since
Total Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+36.0%——
1 year+23.0%——
3-year CAGR+6.1%——
5-year CAGR——
10-year CAGR——

Total Liabilities history

USD · from the balance sheet

Latest · FY2025
14.16M USD
Year-over-year change
+23.0%
4-year CAGR
+7.2%

Total Liabilities vs competitors

How IRMD compares with its peers on the latest reported figures

  • IRMD's Mar 2026 total liabilities of $15.88M is the lowest of the 11 companies compared; the peer median is $836.59M.
  • Its year-over-year change of +36.0% is the 2nd highest of 11, against a peer median of +0.9%.
  • Total liabilities amounts to 13.9% of total assets for IRMD, versus a peer median of 50.4%.
IRMD Competitors Peer median
Total Liabilities for IRMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CTEVClaritev CorporationMar 2026$5.07B +0.1%-3.2%104.8%
AHCOAdaptHealth Corp.Apr 2026$2.91B +1.6%-3.0%65.8%
IARTIntegra LifeSciences Holdings CorporationMar 2026$2.54B +0.3%+7.1%70.9%
GDRXGoodRx Holdings, Inc.Mar 2026$1.4B +118.3%-0.1%69.2%
TNDMTandem Diabetes Care, Inc.Mar 2026$1.02B +33.1%+5.8%88.5%
OPKOPKO Health, Inc.Mar 2026$652.19M -20.1%+3.1%35.1%
INMDInMode Ltd.Mar 2026$89.58M +5.0%-2.5%11.9%
MDXGMiMedx Group, Inc.Mar 2026$65.74M -2.8%-3.9%21.3%
AXGNAxoGen, Inc.Sep 2026$54.24M -43.3%-0.5%9.9%
CRONCronos Group Inc.Mar 2026$48.45M +24.0%-9.1%4.1%
IRMDIRadimed CorporationMar 2026$15.88M +36.0%+6.1%13.9%
Peer median (excluding IRMD) $836.59M+0.9%-1.5%50.4%

Competitors are the stored peer set for IRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents62M57.96M49.76M52.23M51.16M
Short-term Investments501.86K0000
Net Receivables5.14M13.27M12.22M10.56M13.67M
Inventory4.3M5.37M12.82M10.4M11.62M
Other Current Assets1M630.96K1.19M2.05M4.76M
Total Current Assets76.24M77.49M76M75.24M81.2M
Property, Plant & Equipment (Net)4.55M4.61M11.33M16.97M23.86M
Goodwill00000
Intangible Assets1.12M2.07M2.52M3.1M3.38M
Long-term Investments00000
Tax Assets765.1K700.87K2.12M2.82M94K
Other Non-current Assets201.33K648.67K181.45K198.91K239K
Total Non-current Assets6.64M8.02M16.15M23.08M27.57M
Total Assets82.88M85.51M92.16M98.33M108.78M
Account Payables782.9K1.8M1.86M1.9M1.82M
Short-term Debt00000
Tax Payables140.32K121.92K353.28K163K0
Deferred Revenue2.55M3.37M2.57M2.26M2.87M
Other Current Liabilities255.32K94.03K367.46K268.27K457K
Total Current Liabilities6.82M8.55M16.33M8.51M10.18M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.68M1.38M2.79M2.99M3.98M
Other Non-current Liabilities00000
Total Non-current Liabilities3.88M3.29M4.41M2.99M3.98M
Total Liabilities10.71M11.84M20.74M11.51M14.16M
Common Stock1.25K1.26K1.27K1.27K1K
Retained Earnings46.99M47.26M43.26M56.79M64.23M
Accumulated OCI17.01K0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity72.17M73.67M71.42M86.82M94.62M
Total Debt2.48M2.21M2.04M154.69K0
Net Debt(59.52M)(55.76M)(47.72M)(52.08M)(51.16M)

IRadimed Corporation

NASDAQ:IRMD

Intrinsic Alpha fair value

Locked

Current Price

$82.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.